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parameters). There is no correlation between the severity 
of OSA and BP levels in 24 h, during daytime, during the 
sleep and serum levels of LDL and HDL cholesterol.
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Introduction
Obstructive sleep apnea (OSA) is the most common form 
of sleep-related breathing disorder [3]. Obstructive sleep 
apnea is a chronic disease characterized by recurrent epi-
sodes of partial or total obstruction of the upper airway 
during sleep (obstructive respiratory events), and is con-
sidered an important cause of morbidity and mortality. As 
a result of this obstruction, there is a reduction or absence 
of airflow, causing a consequent alveolar hypoventilation 
with oxyhemoglobin desaturation, and prolonged cases, the 
increase of carbon dioxide (PaCO2) [1]. Obstructive respir-
atory events, besides resulting in oxyhemoglobin desatura-
tion (hypoxia), cause an activation of the central nervous 
system causing an awakening soon and consequent sleep 
fragmentation, which is the main mechanism that deter-
mines excessive daytime sleepiness [13]. Hypoxia stimu-
lates the arterial chemoreceptors (carotid receptors) which 
increase the activity of the sympathetic nervous system. 
Therefore, patients with OSA have a heightened response 
of these receptors when compared with individuals not 
apneic [11]. The cycles of hypoxia and reoxygenation may 
alter oxidative balance and induce an increase of free radi-
cals, which are important factors for pathological conse-
quences of OSA [8].
In healthy individuals, sleep is associated with a reduc-
tion in blood pressure (BP). The physiological decrease 
Abstract The purpose of this study was to evaluate the 
correlation between the severity of obstructive sleep apnea 
(OSA) and the levels of blood pressure (BP), lipids and 
glucose, as intermittent hypoxia increases BP, changes the 
oxidative balance, and can induce the formation of free 
radicals and atherogenesis. 32 patients were evaluated 
about BP during wakefulness and sleep, total cholesterol 
and lipids, LDL (low-density lipoprotein), HDL (high-
density lipoprotein), triglycerides, glucose and polysom-
nography. They were divided into four groups according 
to the respiratory events per hour of sleep (RDI): control 
group (RDI < 5), Group I (RDI 5–15), Group II (RDI 15–
30), Group III (RDI > 30). There was no increase in BP in 
groups’ cases, the verification of systolic (p = 0.429) and 
diastolic (p = 0.475) BP in 24 h, systolic (p = 0.277) and 
diastolic (p = 0.143) BP during wakefulness, and systolic 
(p = 0.394) and diastolic (p = 0.703) BP during sleep in 
the control group. When implementing the Spearman cor-
relation test, a correlation directly proportional to the sever-
ity of the disease was not observed. Regarding the level 
of serum total cholesterol (p = 0.092), LDL (p = 0.242), 
HDL (p = 0.517), triglycerides (p = 0.947), total lipids 
(p = 0.602) and glucose (0.355), there was no statistically 
significant difference between groups (p > 0.05 for all 
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of systolic and diastolic BP during sleep is 10–15 % com-
pared to the levels of wakefulness [20]. With parasym-
pathetic predominance and low serum levels of catecho-
lamines, NREM (no rapid eye movement) is marked by 
a reduction in heart rate, BP, heart activity and systemic 
vascular resistance. During REM (rapid eye movement) 
sleep, however, there is an increased activity of the sym-
pathetic nervous system, heart rate and BP, clinically 
important effects for those with preexisting cardiovascu-
lar disease, in addition to muscle atony which makes the 
upper airway more susceptible to collapse and oxyhemo-
globin desaturation deeper. Hence, REM sleep is physi-
ologically important in the OSA [13].
Sleep deprivation can also match an important risk fac-
tor for high BP. The “Cross-sectional Sleep Heart Health 
Study” [5] states that the chance of having hypertension 
was higher in those who slept <6 h per night. According to 
the study by Hla et al. [6], the cardiovascular consequences 
of OSA are frequent and the most prevalent is hypertension.
The diagnosis of OSA is required to determine the pres-
ence of recurrent apneas and/or hypopneas and/or arousal 
related to respiratory effort (DRER) during sleep recorded 
by overnight polysomnography performed in a sleep labo-
ratory [2]. Quantifying these respiratory events per hour of 
sleep (RDI), the disease is classified based on severity as 
mild, moderate and severe [1].
The intermittent respiratory events that lead to desatura-
tion and oxyhemoglobin to hypercapnia cause an activation 
of the sympathetic nervous system responses to changing 
barometric chemoreceptors resulting in an increase in sys-
tolic BP and consequent hypertension or exacerbation of 
this condition. The intermittent hypoxia may also alter the 
reactivity of vascular dilation and constriction, and lead to 
the formation of free radicals, which are highly reactive 
chemical molecules that react with nucleic acids, lipids and 
proteins, altering cellular metabolism and resulting in cell 
damage and atherogenesis [7, 8]. Being OSA a disease with 
significant systemic repercussions, the main objective of this 
study was to investigate the relationship between the sever-
ity of the disease with hypertension and the degree of meta-
bolic dysfunction by measuring serum lipid and glucose.
Methods
Fifty adult patients, aged between 23 and 83 years, 28 
males and 22 females, were evaluated after acceptance of 
the Terms of Consent approved by the ethics committee of 
the University of the Alagoas State, number 1152. There 
was no financial support as well as conflicts of interest and 
off-label or investigational use.
Of the 50 patients who participated in the initial sur-
vey, 18 did not complete all of the exams or did not return 
the survey. Therefore, 32 patients remained in the study, 
of whom 20 were male, aged 23–83 years and 12 were 
female, aged between 41 and 76 years.
Inclusion criteria for the study were:
•	 Being an adult;
•	 Has untreated OSA (except for the control group); and
•	 Accepted to participate.
The exclusion criteria for the study were:
•	 Being a carrier of chronic cardiac, pulmonary, renal, 
hematologic or neurologic;
•	 Being in drug treatment for dyslipidemia; and
•	 Being in drug treatment for diabetes mellitus.
For hypertensive patients using antihypertensive medi-
cation, discontinuation of medication for a minimum of 
24 h prior to the ambulatory BP monitoring was required.
The patients were divided into four groups according to 
the severity of the disease:
CONTROL GROUP: comprising six patients with 
standard RDI (less than 5/h of sleep).
GROUP I: Nine patients with a RDI between 5 and 15/h 
of sleep, classified as having mild OSA.
GROUP II: Six patients with a RDI between 15 and 30/h 
of sleep, considered to have moderate OSA.
GROUP III: Eleven patients with a greater than RDI 
30/h of sleep, classified as having severe OSA.
In the first evaluation, each selected patient was ques-
tioned regarding age, personal history of hypertension, 
diabetes mellitus, hypercholesterolemia, and smoking hab-
its. Weight (kg) and height (m) were measured on anthro-
pometric scales Welmy® to calculate the body mass index 
(BMI), and BP was checked using a manual blood pres-
sure meter BD® and stethoscope BD®. The equipment was 
placed in one arm with the patient seated. Then, the follow-
ing exams were conducted:
1. Laboratory: complete blood count, serum levels of total 
cholesterol, LDL (low-density lipoprotein) and HDL 
(high-density lipoprotein), triglycerides and total lipids, 
fasting glucose, renal function tests (through meas-
urement of serum urea and creatinine) and liver func-
tion through the measurement of glutamic-oxaloacetic 
transaminase (SGOT), glutamic pyruvate transaminase 
(GPT) and gamma glutamate transferase (gamma-GT).
2. Overnight polysomnography (PSG), to determine RDI, 
average heart rate and lowest oxyhemoglobin satura-
tion during sleep.
3. Ambulatory blood pressure monitoring (ABPM) to 
evaluate the BP for 24 h, distinguishing the mean BP 
awake and during sleep.
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Overnight polysomnography
Polysomnography was performed in a Sleep Laboratory 
Service of a reference in Otolaryngology Alagoas State in 
Brazil, following the 10–20 International System of elec-
trode placement cranial central (C3/A2 and C4/A1) and 
occipital (O1/A2 and O2/A1) to obtain the electroenceph-
alogram (EEG). Electrodes were also fixed at the outer 
corner of each eye to detect eye movements, resulting in 
electrooculogram, and electrodes at the chin, to obtain the 
electromyogram. Through the electroencephalogram, elec-
trooculogram and chin electromyogram, one can deter-
mine the sleep architecture of the individual, observing the 
distribution of sleep stages and the presence of recurrent 
arousals that fragment sleep. Electrodes were also placed 
on the anterior chest for electrocardiogram; electrodes 
in the lower limbs (at the tibialis anterior muscle of each 
leg) to detect possible movements of the lower limbs. For 
this examination, we used a digital polygraph ICELERA® 
26-channel model Fast-Poly 26i. The filters used for EEG 
and electrooculogram were low-pass 35 Hz. For the elec-
tromyogram of the chin and lower limbs, we used low-pass 
filters 100 Hz and 10 Hz high pass, and for the electrocar-
diogram (ECG), we used low-pass filters 70 Hz.
To verify the flow of air through the upper airways, 
temperature sensors oro-nasal (Icelera thermistor®) and 
nasal pressure (Icelera cannula®) were used, necessitating 
the presence of at least one of them for the determination 
of apnea and hypopnea index. The thoracic and abdomi-
nal belts were placed to check the presence or absence of 
respiratory effort, which allows classifying the respiratory 
event as obstructive, central or mixed. A position sensor 
was attached to the chest strap, and snore sensor was posi-
tioned parallel to the trachea in the neck. To assess oxygen 
saturation, pulse oximetry second finger was placed on a 
hand. Each patient remained from 22:00 to 6:00 at the 
Sleep Laboratory, being permanently accompanied by a 
technical expert in nursing.
Ambulatory blood pressure monitoring
The ABPM is a diagnostic method that allows the evalua-
tion of daytime and nighttime BP, checking possible vari-
ations even during sleep. A digital sphygmomanometer 
Spacelabs® was positioned in one of the upper and remained 
so for 24 h. BP checks were carried out every 20 min dur-
ing the day and every 30 min at night. Averages of systolic 
and diastolic total in wakefulness and sleep were evaluated.
Analysis
For statistical analysis, we obtained the mean and standard 
deviation of each variable. The level of significance was set 
at p < 0.05. To compare the mean, we used the nonparamet-
ric Kruskal–Wallis. To verify the correlation between the 
severity of OSA with systemic levels of diurnal and noc-
turnal BP and serum levels of total cholesterol and its frac-
tions (LDL and HDL), triglycerides, total lipids and fast-
ing glucose, we used the Test Spearman correlation (Cc). 
The programs used were Microsoft® Office Excel® 2007 
and SPSS (Statistical Package for Social Sciences for Win-
dows) version 17.0. In cases where a significant difference 
occurred between groups, post-nonparametric Mann–Whit-
ney test was applied, to see in which groups this difference 
existed. For statistically significant results, an asterisk was 
used to characterize them. For the results that were not sig-
nificant, we used the abbreviation NS.
Results and discussion
The results obtained were as follows:
(A) Age: the average standard deviation of age among 
the control subjects was 48.2 years and 16.4, respec-
tively. In the other groups, the mean and standard devia-
tion (SD) age were: Group I: 52.3 years, SD 12.9; Group 
II: 43.7 years, SD 9.0; and Group III: 49.7 years, SD 18.6 
(p = 0.749) (Table 1).
(B) Sex: male, 50 % of the control group, 55.6 % of 
Group I, 100 % in Group II, and 54.5 % in Group III. There 
was therefore a proportionality between the sexes (approxi-
mately 1:1) between the groups, except for Group II, where 
all subjects were male (Table 2).
(C) BMI: the mean and standard deviation of BMI (kg/
m2) groups were, respectively, control group: 26.1 and 3.3; 
Group I: 28.3 and 2.8, Group II: 30.0 and 4.0; Group III: 
30.9 and 3.3. There was not therefore a statistically signifi-
cant difference between groups (p = 0.075) (Table 1).
Table 1  Anthropometric and 
blood pressure of the first 
assessment patients
Source: author of this 
dissertation (2011)
Results not significant between 
groups
Variables Control Group I Group II Group III p
Mean SD Mean SD Mean SD Mean SD
Age (years) 48.2 16.4 52.3 12.9 43.7 9.0 49.7 18.6 0.749
BMI (kg/m2) 26.1 3.3 28.3 2.8 30.0 4.0 30.9 3.3 0.075
Systolic BP (mmHg) 113.3 10.3 125.6 14.2 126.7 19.7 124.5 16.3 0.339
Diastolic BP (mmHg) 73.3 5.2 79.4 8.1 82.5 7.6 81.8 12.5 0.238
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(D) BP: At the first evaluation of each patient, the BP 
and diastolic blood obtained were also not statistically sig-
nificant different between the groups (p = 0.339 for systolic 
and p = 0.238 for diastolic BP), the average and standard 
deviation of each group, respectively, for systolic BP: control 
group: 113.3 and 10.3; Group I: 125.6 and 14.2; Group II: 
126.7 and 19.7; Group III: 124.5 and 16.3, and for diastolic 
BP of: control group: 73.3 and 5.2; Group I: 79.4 and 8.1, 
Group II: 82.5 and 7.6, Group III: 81.8 and 12.5 (Table 1).
With respect to the information from the questionnaires 
regarding patients’ case histories:
•	 Over 50 % of individuals with sleep apnea severe 
(Group III), reported being carriers of hypertension, 
whereas this percentage was lower in the other groups 
(Table 2).
•	 The presence of diabetes mellitus was reported in three 
patients in Group I, two males and one female, and only 
one patient in Group III, this male. Its occurrence was 
not reported in the remaining participants (Table 2).
•	 When asked about the occurrence of increased serum 
levels of total cholesterol, LDL, HDL and triglycer-
ides, 16.7 % of control subjects reported present. The 
response also was positive for 55.6 % of patients in 
Group I and 16.7 % of patients in Group II. No patient 
in Group III reported this change (Table 2).
•	 Only 22.2 % of patients in Group I and 16.7 % of Group 
II patients were smokers, and the smoking habit was not 
reported in the other groups (Table 2).
In the analysis of the PSG, there was a statisti-
cally significant difference between the groups with 
respect to RDI and minimum oxyhemoglobin satura-
tion (p = 0.000 and p = 0.004, respectively). As heart 
rate, there was no statistically significant difference 
(p = 0.079) (Table 3).
Post-nonparametric Mann–Whitney test was applied to 
see which groups had a difference. Regarding the RDI, a 
significant difference was seen between the control group 
and the other groups [control and Group I (p = 0.001) and 
Table 2  Information relating 
to sex and the presence of 
hypertension, diabetes mellitus, 
hypercholesterolemia
Source: author of this 
dissertation (2011)
Variables Control Group I Group II Group III
n % n % n % n %
Sex
 Male 3 50.0 5 55.6 6 100.0 6 54.5
 Female 3 50.0 4 44.4 0 0.0 5 45.5
Hypertension
 Yes 2 33.3 3 33.3 1 16.7 6 54.5
 No 4 66.7 6 66.7 5 83.3 5 45.5
Diabetes mellitus
 Yes 0 0.0 3 33.3 0 0.0 1 9.1
 No 6 100.0 6 66.7 6 100.0 10 90.9
Hypercholesterolemia
 Yes 1 16.7 5 55.6 1 16.7 0 0.0
 No 5 83.3 4 44.4 5 83.3 11 100.0
Smoking
 Yes 0 0.0 2 22.2 1 16.7 0 0.0
 No 6 100.0 7 77.8 5 83.3 11 100.0
Table 3  Mean and standard deviation of the respiratory events per hour of sleep, heart rate and oxygen saturation in minimal by overnight poly-
somnography
Source: author of this dissertation (2011)
* Statistically significant differences between groups regarding the RDI and minimal oxygen saturation of O2 [NADIR O2 (%)]
Variables Control Group I Group II Group III p
Mean SD Mean SD Mean SD Mean SD
RDI (events/h sleep) 1.2 1.6 9.9 2.4 21.9 6.2 46.2 15.3 0.000*
Heart rate (bpm) 57.3 5.2 65.3 4.0 64.4 5.5 64.5 8.7 0.079
NADIR O2 (%) 89.2 5.1 86.7 3.0 83.3 5.8 75.9 9.2 0.004*
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control Group II (p = 0.004), and control and Group III 
(p = 0.001)], and also between groups I and II (p = 0.001) 
and groups I and III (p = 0.000) and between groups II 
and III (p = 0.001). As for NADIR O2, the significant dif-
ference occurred between the control group and Group 
III (p = 0.005), and between groups I and III (p = 0.003) 
(Table 4).
There was an increase in blood pressure in the groups 
of cases in the verification of systolic BP (p = 0.429) 
and diastolic (p = 0.475) in 24 h, systolic (p = 0.277) 
and diastolic (p = 0.143) during wakefulness, and sys-
tolic (p = 0.394) and diastolic (p = 0.703) during sleep 
(Table 5). When implementing the Spearman correlation 
test, we did not observe a correlation directly proportional 
to the severity of the disease (Cc = −0.202 for systolic BP 
at 24 h; Cc = −0.202 for diastolic BP at 24 h; Cc = −0.185 
for systolic BP during wakefulness; Cc = −0.107 for dias-
tolic BP during wakefulness; Cc = −0.095 for systolic BP 
during sleep; Cc = 0.027 for diastolic BP during sleep) 
(Table 6).
Regarding the level of serum total cholesterol 
(p = 0.092, Cc = −0.286) of their LDL (p = 0.242, 
Cc = −0.291) and HDL (p = 0.517, Cc = −0.114), triglyc-
erides (p = 0.947, Cc = −0.095), total lipids (p = 0.602, 
Cc = −0.012) and fasting glucose (p = 0.355, Cc = 0.211), 
there was also no significant difference between the groups 
(Tables 7, 8), with no correlation between their values and 
the severity of OSA.
The OSA has a higher prevalence with advancing age. 
Punjabi (2008), in their epidemiological study, showed that 
the disease affects about 3.2 % of people aged 20–44 years, 
11.3 % of those 45–65, and 18.1 % who are between 61 
and 100 years, demonstrating that increasing age has noth-
ing to do with the emergence OSA. In the present study, the 
mean of the population affected was above 40 years, which 
is consistent with their findings.
The frequency of OSA in middle-aged individuals is 
higher in males at a rate 2–3 times greater than in women 
and affects about 4 % of men and 2 % of women over 
30 years [22]. This was not observed in this study because 
there was a proportionality between the sexes of approxi-
mately one woman to one man, except for the group of 
moderate apnea, where all affected individuals were men.
The disease also has a higher prevalence in individu-
als who are obese or overweight. In the study by Peppard 
et al. [15], it was established that a 10 % increase of body 
weight increased risk of developing the disease six times. In 
the present study, we observed a higher body mass index in 
Table 4  Post-nonparametric Mann–Whitney test, to see which 
groups had significant difference
Source: author of this dissertation (2011)
* Statistically significant differences between groups 
Variables Groups p
RDI Control Group I 0.001*
Group II 0.004*
Group III 0.001*
Group I Group II 0.001*
Group III 0.000*
Group II Group III 0.001*
NADIR O2 Control Group I 0.375
Group II 0.128
Group III 0.005*
Group I Group II 0.312
Group III 0.003*
Group II Group III 0.077
Table 5  Mean and standard 
deviation of blood pressure in 
24 h during waking and during 
sleep, through the MAP
Source: author of this 
dissertation (2011)
Results not significants between 
groups
Variables (mmHg) Control Group I Group II Group III p
Mean SD Mean SD Mean SD Mean SD
Systolic BP 24 h 126.7 8.8 126.0 7.6 129.2 3.8 123.6 8.9 0.429
Diastolic BP 24 h 77.7 5.9 77.8 5.7 79.2 3.8 75.6 5.4 0.475
Systolic BP awake 128.8 11.3 130.0 8.8 134.2 3.8 125.6 9.4 0.277
Diastolic BP awake 79.7 8.5 81.8 5.9 85.7 1.6 78.2 6.8 0.143
Systolic BP sleep 119.2 1.6 112.4 8.4 117.5 6.1 117.5 12.1 0.394
Diastolic BP sleep 69.7 3.2 68.6 4.7 71.7 4.1 70.8 6.8 0.703
Table 6  Correlational analysis (test Spearman) between the groups regarding blood pressure in 24 h, during waking and during sleep
Source: author of this dissertation (2011)
Variables BP 24 h (mmHg) BP awake (mmHg) BP sleep (mmHg)
Correlation coefficient Systolic Diastolic Systolic Diastolic Systolic Diastolic
−0.202 −0.202 −0.185 −0.107 −0.095 0.027
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groups of cases than in the control group, with an increase in 
weight proportional to the severity of the disease. Although 
overweight is a significant risk factor for the onset and 
worsening of the disease, other factors such as the presence 
of craniofacial abnormalities [10] and/or anatomical obsta-
cles in the upper airway as adenotonsillar hypertrophy, big 
tongue [18], nasal obstruction, smoking and heredity among 
others [22], should not be overlooked and should be valued 
both in research and in the treatment of OSA.
According to the study by Logan et al. [9], OSA is 
highly prevalent in individuals with cardiovascular disease, 
especially in hypertensive population, affecting approxi-
mately 30–83 % of these. Similar prevalence study was also 
observed in Hla et al. [6], where approximately 40–60 % 
of individuals with untreated OSA had hypertension, and 
among hypertensive patients, about a third had associated 
with OSA. The same was demonstrated subjectively in 
this study, where more than 30 % of apneic reported mild 
to moderate hypertension, and this co-morbidity was even 
more frequent among severe apnea, affecting more than 
50 % of them. However, the objective results obtained by 
the analysis of a BP check in the first assessment performed 
in the doctor, the mean systolic BP and diastolic BP in the 
different groups revealed no cases of BP above normal. This 
fact is probably to be explained by those patients who are 
making use of antihypertensive medication. Epidemiologi-
cal studies like the Wisconsin Sleep Cohort Study [14] and 
Sleep and Heart Health [12] concluded that the association 
between OSA and hypertension is independent of other risk 
factors such as age, obesity, gender, and consumption of 
alcohol and cigarettes. Another study carried out to verify 
OSA as a risk factor for hypertension [7] showed that for 
each respiratory event per hour of sleep, increased around 
1 % risk of this individual having hypertension. Hla et al. 
[9] showed that individuals with OSA with RDI ≥ 5/h had 
higher levels of BP in wakefulness and during sleep as 
compared to the control group. However, this did not occur 
in this study because there was no significant difference 
between the systolic and diastolic BP at first visit, and in the 
evaluation of BP in 24 h during waking and sleep between 
the groups, since there was not a correlation between dis-
ease severity and increased levels of systemic BP.
Moreover, although no significant changes occurred in 
blood pressure in the different groups’ cases, two aspects 
must be considered. The first one is in relation to the num-
ber of heart beats per minute during sleep. Although no sig-
nificant differences occurred between the mean heart rate, 
an increase was observed in this group of cases, objectively 
demonstrating that patients with OSA have an increased 
activity of the sympathetic nervous system when they are 
sleeping, which favors for the emergence or worsening of 
cardiovascular diseases. Normally during NREM sleep, 
there is a drop in the activity of the sympathetic nervous 
system and, consequently, heart rate and BP [22]. But in 
individuals with OSA, there is no drop of physiologi-
cal activity of this system, resulting in inflammatory and 
metabolic effects that bring overhead to the operation of 
the entire cardiovascular system [21]. The other aspect to 
be highlighted is the decrease in the blood level of oxygen 
observed by the average minimum oxyhemoglobin satura-
tion (NADIR O2), and the difference was statistically sig-
nificant between the groups, and their level is inversely 
proportional to the severity of the disease; the smaller the 
oxyhemoglobin saturation, the greater the severity of the 
disease.
With respect to glucose metabolism, Punjabi et al. [16] 
observed an increase in peripheral insulin resistance with 
an increase in the RDI. A RDI ≥ 5 respiratory events/
Table 7  Mean and standard 
deviation of total cholesterol, 
LDL, HDL, triglycerides, lipids 
and fasting glucose
Source: author of this 
dissertation (2011)
Variables (g/dl) Control Group I Group II Group III p
Mean SD Mean SD Mean SD Mean SD
Total cholesterol 212.5 19.1 221.1 37.7 218.2 59.8 187.6 31.8 0.092
LDL 138.1 21.7 145.1 33.3 138.4 50.9 116.7 26.7 0.242
HDL 47.7 11.6 49.9 8.1 41.5 10.4 46.5 12.1 0.517
Triglycerides 231.2 213.7 181.9 110.1 211.3 235.0 175.4 126.7 0.947
Total lipids 688.4 176.5 851.1 292.8 822.8 374.4 732.0 296.3 0.602
Fasting glucose 87.0 9.3 98.9 20.3 85.8 9.5 108.8 49.2 0.355
Table 8  Correlational analysis (test Spearman) between the groups regarding total cholesterol, LDL, HDL, triglycerides, total lipids and fasting 
glucose
Source: author of this dissertation (2011)
Variables Total cholesterol (g/dl) LDL (g/dl) HDL (g/dl) Triglycerides (g/dl) Total lipids (g/dl) Fasting glucose (g/dl)
Correlation coefficient −0.286 −0.291 −0.114 −0.095 −0.012 0.211
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hour was associated with an increased risk for impaired 
glucose tolerance (odds ratio 2.15, 1.05–4.38, 95 % CI) 
after adjustment for BMI and body fat percentage, and 
down 4 % in oxyhemoglobin saturation presented an odds 
ratio of 1.99 (1.11–3.56, 95 % CI) also for glucose toler-
ance. Nevertheless, there was not a significant increase in 
glucose level in affected individuals in this study. Li et al. 
[10] concluded that intermittent hypoxia may contribute 
to the development of hypercholesterolemia in rats, and 
that it increases the HDL cholesterol level, but its activity 
to convert a pro-inflammatory and pro-atherogenic. Girar-
din et al. [4] have shown that patients with OSA showed 
an increase in HDL dysfunctional. Naturally, Spiegel et al. 
[19] in their analysis, found that patients with OSA showed 
an increase in HDL oxidized LDL and dysfunctional, there 
is a strong correlation between the severity of disease and 
oxidative stress caused by it with the respective elevations. 
This was not observed in this study, since there was no sig-
nificant difference between the levels of lipids in affected 
individuals compared to the control group, the same event 
that occurred in the study of Punjabi et al. [16], where the 
LDL and triglyceride levels were not associated with the 
severity of OSA. Therefore, studies to date are conflicting 
regarding the actual occurrence of metabolic disorders such 
as dyslipidemia and hyperglycemia in patients with OSA.
Conclusion
There is no correlation between the severity of OSA and 
elevated blood pressure in 24 h, during wakefulness and 
sleep, as well as elevated the serum levels of total cho-
lesterol, LDL, HDL, triglycerides, and fasting glucose. 
However, the duration of OSA may be an important fac-
tor in the onset or worsening of hypertension and metabolic 
disorders.
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